UF Innovate Launches COVID-19 Resource Section on Website

The new dedicated section offers tools for researchers and startups during the COVID-19 pandemic. As part of UF Innovate’s continuous commitment to inform, it has introduced a COVID-19 Resource Section on the organization’s website. The new page is a comprehensive collection of various tools for researchers and startups, including links to available grants, collaborative efforts, […]

UF Health Researchers Donate Gloves, Masks and Other PPE to Support Frontline Colleagues

Researchers from across the University of Florida and UF Health have joined an urgent effort to collect and donate personal protective equipment, or PPE, to build upon existing stockpiles in support of clinical colleagues on the frontlines of treating COVID-19. By the pallet and truckload, laboratory teams spanning across UF’s many scientific disciplines are amassing […]

Algernon Submits for Ethics Approval for Phase 2 IPF and Chronic Cough Study

UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, is pleased to announce that it has submitted for ethics approval in Australia for its planned Phase 2 study of its re-purposed drug NP-120 (Ifenprodil) for idiopathic pulmonary fibrosis (IPF) and chronic cough. Ethics submission is the next step in the company’s clinical development program […]

UF Health Anesthesiology Team Devises Respirator Mask Made From Existing Hospital Materials

With respiratory masks used by health workers battling the coronavirus in short supply, the University of Florida Health’s department of anesthesiology has developed masks that can be produced in large quantities using materials already found in hospitals and medical facilities. N95 respirator masks have been in high demand worldwide since the outbreak of COVID-19. That led […]

What You Need to Know About the Possible Smell/Taste Link to COVID-19

As more anecdotes surface from physicians around the world about patients with COVID-19 losing their senses of smell and taste, we asked Steven Munger, Ph.D., director of the University of Florida Center for Smell and Taste, located within UF’s McKnight Brain Institute, what science can tell us about the potential link — and what to […]

New Lab Results From Healthtech Startup Bluewave Technologies, Inc. Indicate Ability to Kill Viruses and Bacteria on Fabrics and Other Hard-to-Treat Items – With Possible Applications in the Current Pandemic

New lab results from UF Innovate | The Hub alum Bluewave Technologies, Inc. indicate that when used as directed, its Bluewave device can effectively kill the non-enveloped virus, MS2 Bacteriophage, and Methicillin-Resistant Staphylococcus Aureus (MRSA). Bluewave Technologies is a startup focused on helping healthcare practitioners kill bacteria and viruses on the surfaces of hard-to-clean items. […]

COVID-19 Highlights Need for Blood Donations

As the coronavirus COVID-19 pandemic continues to escalate, experts are warning of a dire shortage of blood as donors stay home and blood drives across the country are canceled.   People should continue to donate blood while taking appropriate precautions and following guidelines from the Centers for Disease Control and Prevention about social distancing and hand […]

UF Researchers Lead the Way in Rapidly Designing, Building Low-Cost, Open-Source Ventilator

As a University of Florida mechanical engineering student decades ago, Samsun Lampotang, Ph.D., helped respiratory therapist colleagues build a minimal-transport ventilator that became a commercial success. So, when the coronavirus pandemic hit and he heard the desperate international plea for thousands of more ventilators, the longtime UF professor of anesthesiology set out to build a […]

Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant

UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), and Inovio Pharmaceuticals Inc., a company developing DNA medicines for infectious diseases and cancer, announced that the Department of Defense (DOD) has awarded Ology Bioservices with a contract valued at $11.9 million to work with Inovio on […]